Gender differences in N-alkyl protoporphyrin IX production in rats after the administration of porphyrinogenic xenobiotics

Drug Metabolism and Disposition

Volumn 26, Issue 8, 1998, Pages 739-744

  Wong, Simon G W ^b   Kobus, Susan M ^b   McNamee, James P ^b   Marks, Gerald S ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

3 [(ARYLTHIO)ETHYL]SYDNONE; 4 ETHYL 1,4 DIHYDRO 2,6 DIMETHYL 3,5 DIETHOXYCARBONYLPYRIDINE; ALPHA NAPHTHOFLAVONE; BETA NAPHTHOFLAVONE; CYTOCHROME P450 ISOENZYME; DEXAMETHASONE; FERROCHELATASE; N VINYLPROTOPORPHYRIN; PHENOBARBITAL; PROTOPORPHYRIN; TROLEANDOMYCIN; UNCLASSIFIED DRUG; XENOBIOTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME INACTIVATION; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEX DIFFERENCE;

ANIMALS; ARYL HYDROCARBON HYDROXYLASES; BENZOFLAVONES; CYTOCHROME P-450 CYP1A2; CYTOCHROME P-450 CYP3A; CYTOCHROME P-450 ENZYME SYSTEM; DICARBETHOXYDIHYDROCOLLIDINE; ENZYME ACTIVATION; FEMALE; ISOENZYMES; MALE; OXIDOREDUCTASES, N-DEMETHYLATING; PROTOPORPHYRINS; RATS; RATS, SPRAGUE-DAWLEY; SEX FACTORS; SYDNONES;

ANIMALIA; STAPHYLOCOCCUS PHAGE 3A;

EID: 0031817707     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Augusto O, Beilan HS and Ortiz de Montellano PR (1982) The catalytic mechanism of cytochrome P-450: spin-trapping evidence for one-electron substrate oxidation. J Biol Chem 257:11288-11295.
2. Chang TK, Gonzalez FJ and Waxman DJ (1994) Evaluation of triacetyloleandomycin, alpha-naphthoflavone and diethyldithiocarbamate as selective chemical probes for inhibition of human cytochromes P450. Arch Biochem Biophys 311:437-442.
3. Coffman BL, Ingall G and Tephly TR (1982) The formation of N-alkylprotoporphyrin IX and destruction of cytochrome P-450 in the liver of rats after treatment with 3,5-diethoxycarbooyl1,4-dihydrocollidine and its 4-ethyl analog. Arch Biochem Biophys 218:220-224.
4. Cooper KO, Reik LM, Jayyosi Z, Bandiera S, Kelly M, Ryan DE, Daniel R, McCluskey SA, Levin W and Thomas PE (1993) Regulation of two members of the steroid-inducible cytochrome P450 subfamily (3A) in rats. Arch Biochem Biophys 301:345-354.
5. Correia MA, Decker C, Sugiyama K, Caldera P, Bornheim L, Wrighton SA, Rettie AE and Trager WF (1987) Degradation of rat hepatic cytochrome P-450 heme by 3,5-dicarbethoxy-2,6-dimethyl-4-ethyl-1,4-dihydropyridine to irreversibly bound protein adducts. Arch Biochem Biophys 258:436-451.
6. De Matteis F, Gibbs AH and Hollands C (1983) N-Alkylation of the haem moiety of cytochrome P-450 caused by substituted dihydropyridines: preferential attack of different pyrrole nitrogen atoms after induction of various cytochrome P-450 isoenzymes. Biochem J 211:455-461.
7. De Matteis F, Gibbs AH and Smith AG (1980) Inhibition of protohaem ferro-lyase by N-substituted porphyrins: structural requirements for the inhibitory effect. Biochem J 189:645-648.
8. De Matteis F and Marks GS (1996) Cytochrome P450 and its interactions with the heme biosynthetic pathway [Review] [59 refs]. Can J Physiol Pharmacol 74:1-8.
9. Ghosal A, Satoh H, Thomas PE, Bush E and Moore D (1996) Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cDNA-expressed human cytochrome P450. Drug Metab Dispos 24:940-947.
10. Gonzalez FJ, Song BJ and Hardwick JP (1986) Pregnenolone 16 alpha-carbonitrile-inducible P-450 gene family: gene conversion and differential regulation. Mol Cell Biol 6:2969-2976.
11. Grab LA, Swanson BA and Ortiz de Montellano PR (1988) Cytochrome P-450 inactivation by 3-alkylsydnones: mechanistic implications of N-alkyl and N-alkenyl heme adduct formation. Biochemistry 27:4805-4814.
12. Guengerich FP, Dannan GA, Wright ST, Martin MV and Kaminsky LS (1982) Purification and characterization of liver microsomal cytochromes P-450: electrophoretic, spectral, catalytic, and immunochemical properties and inducibility of eight isozymes isolated from rats treated with phenobarbital or beta-naphthoflavone. Biochemistry 21:6019-6030.
13. Halpert JR (1995) Structural basis of selective cytochrome P450 inhibition. Annu Rev Pharmacol Toxicol 35:29-53.
14. Halpert JR, Guengerich FP, Bend JR and Correia MA (1994) Selective inhibitors of cytochromes P450 [Review] [120 refs]. Toxicol Appl Pharmacol 125:163-175.
15. Kimmett SM, McNamee JP and Marks GS (1994) Mechanism-based inactivation of hepatic cytochrome P450 2C6 and P450 3A1 following in vivo administration of 3,5-diethoiycarbonyl-1,4-dihyaro-2,6-dimethyl-4-ethylpyridine to rats: differences from previously observed in vitro results. Biochem Pharmacol 47:2069-2078.
16. Lee JS, Jacobsen NE and Ortiz de Montellano PR (1988) 4-Alkyl radical extrusion in the cytochrome P-450-catalyzed oxidation of 4-alkyl-1,4-dihydropyridines. Biochemistry 27: 7703-7710.
17. Marks GS, Allen DT, Johnston CT, Sutherland EP, Nakatsu K and Whitney RA (1985) Suicidal destruction of cytochrome P-450 and reduction of ferrochelatase activity by 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine and its analogues in chick embryo liver cells. Mol Pharmacol 27:459-465.
18. Marks GS, McCluskey SA, Mackie JE, Riddick DS and James CA (1988) Disruption of hepatic heme biosynthesis after interaction of xenobiotics with cytochrome P-450. [Review] [40 refs]. FASEB J 2:2774-2783.
19. McCluskey SA, Marks GS, Sutherland EP, Jacobsen N and Ortiz de Montellano PR (1986) Ferrochelatase-inhibitory activity and N-alkylprotoporphyrin formation with analogues of 3,5-diethoxycarbonyl-1,4-dihydro-2,4, 6-trimethylpyridine (DDC) containing extended 4-alkyl groups: implications for the active site of ferrochelatase. Mol Pharmacol 30:352-357.
20. McCluskey SA, Marks GS, Whitney RA and Ortiz de Montellano PR (1988) Differential inhibition of hepatic ferrochelatase by regioisomers of N-butyl-, N-pentyl-, N-hexyl-, and N-isobutylprotoporphyrin IX. Mol Pharmacol 34:80-86.
21. McNamee JP and Marks GS (1996) Cytochrome P4503A is the major source of N-vinylprotoporphyrin IX formation after administration of 3-[2-(2,4,6-trimethylphenyl)thioethyl]-4-methylsydnone to untreated and dexamethasone-pretreated rats. Drug Metab Dispos 24:872-878.
22. Morgan ET, MacGeoch C and Gustafsson JA (1985) Hormonal and developmental regulation of expression of the hepatic microsomal steroid 16 alpha-hydroxylase cytochrome P-450 apoprotein in the rat. J Biol Chem 260:11895-11898.
23. Ortiz de Montellano PR (1989) Cytochrome P-450 catalysis: radical intermediates and dehydrogenation reactions [Review] [27 refs]. Trends Pharmacol Sci 10:354-359.
24. Ortiz de Montellano PR, Beilan HS and Kunze KL (1981a) N-Alkylproloporphyrin IX formation in 3,5-dicarbethoxy-1,4-dihydrocollidine-treated rats: transfer of the alkyl group from the substrate to the porphyrin. J Biol Chem 256:6708-6713.
25. Ortiz de Montellano PR, Beilan HS and Kunze KL (1981b) N-Methylprotoporphyrin IX: chemical synthesis and identification as the green pigment produced by 3,5-diethoxycarbonyl-1,4-dihydrocollidine treatment. Proc Natl Acad Sci USA 78:1490-1494.
26. Ortiz de Montellano PR and Grab LA (1986) Inactivation of cytochrome P-450 during catalytic oxidation of a 3-[(arylthio)ethyl]sydnone: N-vinyl heme formation via insertion into the Fe-N bond. J Am Chem Soc 108:5584-5589.
27. Ortiz de Montellano PR, Kunze KL, Cole SP and Marks GS (1980) Inhibition of hepatic ferrochelatase by the four isomers of N-methylprotoporphyrin IX. Biochem Biophys Res Commun 97:1436-1442.
28. Ortiz de Montellano PR, Kunze KL, Cole SP and Marks GS (1981c) Differential inhibition of hepatic ferrochelatase by the isomers of N-ethylproloporphyrin IX. Biochem Biophys Res Commun 103:581-586.
29. Riddick DS, Mackie IE, Massey TE and Marks GS (1990) 3,5-Diethoxycarbonyl-2,6-dimethyl-4-ethyl-1,4-dihydropyridine inactivates rat liver cytochrome P-450c, but not its orthologue, rabbit lung form 6. Can J Physiol Pharmacol 68:370-373.
30. Riddick DS, Park SS, Gelboin HV and Marks GS (1989) Effects of a series of 4-alkyl analogues of 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine on the major inducible cytochrome P-450 isozymes of rat liver. Mol Pharmacol 35:626-634.
31. Riddick DS, Park SS, Gelboin HV and Marks GS (1990) Effects of 4-alkyl analogues of 3,5-dietboxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine on hepatic cytochrome P-450 heme, apoproteins, and catalytic activities following in vivo administration to rats. Mol Pharmocol 37:110-136.
32. Roos PH and Mahnke A (1996) Metabolite complex formation of orphenadrine with cytochrome P450. Involvement of CYP2C11 and CYP3A isozymes. Biochem Pharmacol 52:73-84.
33. Shimada M, Murayama N, Yamauchi K, Yamazoe Y and Kato R (1989) Suppression in the expression of a male-specific cytochrome P450, P450-male: difference in the effect of chemical inducers on P450-male mRNA and protein in rat livers. Arch Biochem Biophys 270:578-587.
34. Stejskal R, Itabashi M, Stanek J and Hruban Z (1975) Experimental porphyria induced by 3-(2,4,6-trimethylphenyl)-thioethyl)-4 methylsydnone. Virchows Arch Biol Cell Path 18 :83-100.
35. Sutherland EP, Marks GS, Grab LA and Ortiz de Montellano PR (1986) Porphyrinogenic activity and ferrochelatase-inhibitory activity of sydnones in chick embryo liver cells. FEBS Lett 197:17-20.
36. Swinney DC, Ryan DE, Thomas PE and Levin W (1987) Regioselective progesterone hydroxylation catalyzed by eleven rat hepatic cytochrome P-450 isozymes. Biochemistry 24:7073-7083.
37. Tephly TR, Black KA, Green MD, Coffman BL, Dannan GA and Guengerich FP (1986) Effect of the suicide substrate 3,5-diethoxycarbonyl-2,6-dimethyl-4-ethyl-1,4-dihydropyridine on the metabolism of xenobiotics and on cytochrome P-450 apoproteins. Mol Pharmacol 29:81-87.
38. Tephly TR, Gibbs AH and De Matteis F (1979) Studies on the mechanism of experimental porphyria produced by 3,5-diethoxycarbonyl-1,4-dihydrocollidine: rote of a porphyrin-like inhibitor of protohaem ferro-lyase. Biochem J 180:241-244.
39. Waxman DJ (1984) Rat hepatic cytochrome P-450 isoenzyme 2c: identification as a male-specific, developmentally induced steroid 16 alpha-hydroxylase and comparison to a female-specific cytochrome P-450 isoenzyme. J Biol Chem 259:15481-15490.
40. Waxman DJ (1988) Interactions of hepatic cytochromes P-450 with steroid hormones: regios-electivity and stereospecificity of steroid metabolism and hormonal regulation of rat P-450 enzyme expression [Review] [76 refs]. Biochem Pharmacol 37:71-84.
41. Waxman DJ, Dannan GA and Guengerich FP (1985) Regulation of rat hepatic cytochrome P-450: age-dependent expression, hormonal imprinting, and xenobiotic inducibility of sex-specific isoenzymes. Biochemistry 24:4409-4417.
42. Wrighton SA, Maurel P, Schuetz EG, Watkins PB, Young B and Guzelian PS (1985) Identification of the cytochrome P-450 induced by macrolide antibiotics in rat liver as the glucocorticoid responsive cytochrome P-450p. Biochemistry 24:2171-2178.
43. Zaphiropoulos PG, Mode A, Norstedt G and Gustafsson JA (1989) Regulation of sexual differentiation in drug and steroid metabolism [Review] [42 refs]. Trends Pharmacol Sci 10:149-153.